Chemotherapy of canine leishmaniosis.

作者: Gad Baneth , Susan E Shaw

DOI: 10.1016/S0304-4017(02)00115-2

关键词:

摘要: Visceral leishmaniosis is a widespread and potentially fatal disease of dogs humans common in the Mediterranean region, Middle East, South America. Canine most frequently treated with drugs meglumine antimoniate, allopurinol, amphotericin B, or combination antimoniate allopurinol. Therapy currently used often achieves temporary clinical improvement changes immunologic parameters restoration ability to mount parasite-specific cell mediated responses decrease anti-leishmanial antibody titers. However, treatment usually does not prevent relapse eliminate parasite carriage. Due current lack an ultimate effective therapy for canine leishmaniosis, new drugs, delivery systems strategies are necessary achieve consistent parasitological cure infected dogs.

参考文章(36)
M. Gramiccia, L. Gradoni, S. Orsini, Decreased sensitivity to meglumine antimoniate (Glucantime) ofLeishmania infantumisolated from dogs after several courses of drug treatment Annals of Tropical Medicine & Parasitology. ,vol. 86, pp. 613- 620 ,(1992) , 10.1080/00034983.1992.11812717
J. Alvar, R. Molina, M. San Andrés, M. Tesouro, J. Nieto, M. Vitutia, F. González, M. D. San Andrés, J. Boggio, F. Rodriguez, A. Sáinz, C. Escacena, Canine leishmaniasis: clinical, parasitological and entomological follow-up after chemotherapy. Annals of Tropical Medicine and Parasitology. ,vol. 88, pp. 371- 378 ,(1994) , 10.1080/00034983.1994.11812879
A Kuhlencord, T Maniera, H Eibl, C Unger, Hexadecylphosphocholine: oral treatment of visceral leishmaniasis in mice. Antimicrobial Agents and Chemotherapy. ,vol. 36, pp. 1630- 1634 ,(1992) , 10.1128/AAC.36.8.1630
C. BELLOLI, G. CRESCENZO, S. CARLI, A. ZAGHINI, G. MENGOZZI, S. BERTINI, P. ORMAS, Disposition of Antimony and Aminosidine Combination After Multiple Subcutaneous Injections in Dogs Veterinary Journal. ,vol. 157, pp. 315- 321 ,(1999) , 10.1053/TVJL.1998.0301
R. MALIK, AJ CRAIG, DI WIGNEY, P. MARTIN, DN LOVE, Combination chemotherapy of canine and feline cryptococcosis using subcutaneously administered amphotericin B Australian Veterinary Journal. ,vol. 73, pp. 124- 128 ,(1996) , 10.1111/J.1751-0813.1996.TB10003.X
Javier Moreno, Javier Nieto, Cristina Chamizo, Fernando González, Fernando Blanco, Douglas C. Barker, Jorge Alvar, The immune response and PBMC subsets in canine visceral leishmaniasis before, and after, chemotherapy Veterinary Immunology and Immunopathology. ,vol. 71, pp. 181- 195 ,(1999) , 10.1016/S0165-2427(99)00096-3
Abdelkebir Rhalem, Hamid Sahibi, Saâdia Lasri, Charles L Jaffe, Analysis of immune responses in dogs with canine visceral leishmaniasis before, and after, drug treatment. Veterinary Immunology and Immunopathology. ,vol. 71, pp. 69- 76 ,(1999) , 10.1016/S0165-2427(99)00088-4
Josep Enric Valladares, Cristina Riera, Pedro González-Ensenyat, Angel Dı́ez-Cascón, Georgina Ramos, Laia Solano-Gallego, Montserrat Gállego, Montserrat Portús, Margarita Arboix, Jordi Alberola, Long term improvement in the treatment of canine leishmaniosis using an antimony liposomal formulation Veterinary Parasitology. ,vol. 97, pp. 15- 21 ,(2001) , 10.1016/S0304-4017(01)00389-2
J.A.G. Scott, R.N. Davidson, A.H. Moody, H.R. Grant, D. Felmingham, G.M.S. Scott, P. Olliaro, A.D.M. Bryceson, Aminosidine (paromomycin) in the treatment of leishmaniasis imported into the United Kingdom. Transactions of The Royal Society of Tropical Medicine and Hygiene. ,vol. 86, pp. 617- 619 ,(1992) , 10.1016/0035-9203(92)90151-2